Grace McLaurin
Medical · Hickory, NCNPI 1366441149
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $498,414 of the $553,259 with a category attached, or 90.1%. AbbVie accounts for 61.6% of it on its own, with 7 other manufacturers making up the rest. Among medical clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 633 payments — averaging $874.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341K
- Galderma Laboratories, L.p.$194K
- Revance Therapeutics, Inc.$18K
- Currax Pharmaceuticals LLC$141
- Merz North America, Inc.$98
- Musculoskeletal Transplant Foundation Inc.$68
- plus $35 from 2 others
What the payments were for
- Consulting fees$5,4581%
- Speaking & faculty fees$498,41490%
- Travel & lodging$41,5918%
- Food & beverage$7,7621%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 393 | $340,718 |
| Galderma Laboratories, L.p. | 201 | $194,207 |
| Revance Therapeutics, Inc. | 23 | $17,991 |
| Currax Pharmaceuticals LLC | 10 | $141 |
| Merz North America, Inc. | 3 | $98 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $68 |
| Avion Pharmaceuticals | 1 | $19 |
| Novo Nordisk | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$553,259 in reported general payments places this provider in the 95th percentile of 878 medical providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $14,797 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $15 | $14,79713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 878 medical providers in North Carolina.
Other medical in Hickory
- Joel ThompsonCharlotte$265K
- Virginia JethroCary$213K
- Payal Soni-PatelAsheville$76K
- William JarrettElkin$59K
- Amanda ZimmermanWinston Salem$48K
- David TaylorMorehead City$40K
- Katherine CardSalisbury$39K
- John RobbinsWinston Salem$26K
- Ashley TipperStatesville$23K
- Hannah PalkoPinehurst$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.